Internal Medicine, Infectious Disease · Richmond, VA
NPI
1205805785
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7605 Forest Ave Ste 302
Richmond, VA, 23229
Phone (804) 285-1833
Groups this clinician bills Medicare through
Medicare paid, 2024
$126K
1,485 services
Medicare patients, 2024
437
Average age 74
Drug cost, 2024
$3.5M
2,157 prescriptions
Company payments, 2025
$267
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David M Rowles was code 99232 (hospital e&m - subsequent), 681 times for 212 patients. In total David M Rowles billed 1,485 services in 12 codes, and Medicare paid $126K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 681 | 212 | $64.29 | $44K |
| 99223 Hospital E&M - Initial | Facility | 415 | 355 | $141.18 | $59K |
| 99231 Hospital E&M - Subsequent | Facility | 158 | 93 | $40.25 | $6,359 |
| 99213 Office E&M - Established | Office | 145 | 84 | $67.33 | $9,762 |
| 99233 Hospital E&M - Subsequent | Facility | 47 | 44 | $95.49 | $4,488 |
| 99214 Office E&M - Established | Office | 17 | 16 | $85.02 | $1,445 |
By year: 2022 $156K for 1,493 services; 2023 $114K for 1,397 services; 2024 $126K for 1,485 services.
Medicare prescription drug claims, 2024
In 2024, the drug David M Rowles prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 385 prescriptions and refills. In total David M Rowles wrote 2,157 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 385 | 389 | 38 | $1.6M |
| Tivicay Dolutegravir Sodium | 128 | 136 | 14 | $500K |
| Vancomycin Hcl Generic | 105 | 105 | 24 | $21K |
| Darunavir Generic | 86 | 86 | Under 11 | $50K |
| Cephalexin Generic | 75 | 86 | 15 | $1,324 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 72 | 86 | Under 11 | $332K |
| Ritonavir Generic | 70 | 126 | 12 | $10K |
| Cefazolin Sodium Generic | 69 | 69 | 14 | $3,042 |
| Doxycycline Hyclate Generic | 65 | 73 | 12 | $1,377 |
| Descovy Emtricitabine/Tenofov Alafenam | 65 | 73 | Under 11 | $156K |
| Ceftriaxone Ceftriaxone Sodium | 63 | 63 | 17 | $4,297 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 54 | 94 | 14 | $555 |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 45 | 68 | Under 11 | $22K |
| Cefadroxil Generic | 45 | 55 | Under 11 | $429 |
| Lamivudine-Zidovudine Lamivudine/Zidovudine | 44 | 76 | Under 11 | $8,091 |
Brand drugs: 872 claims; generic drugs: 1,285 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David M Rowles $267 ($267 in general payments such as food, travel and fees) from 4 companies. The largest payer was Shionogi Inc with $189.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.